Can We Tell Patients That IL-23 and TNF-α Inhibition Are “Natural” Ways to Treat Psoriasis?

Abstract

Keywords

single-nucleotide polymorphism biologics p19 IL-23R tumor necrosis factor–α

Get full access to this article

View all access options for this article.

References

Tsunemi

Saeki

Nakamura

et al. Interleukin-12 p40 gene (IL12B) 3′-untranslated region polymorphism is associated with susceptibility to atopic dermatitis and psoriasis vulgaris. J Dermatol Sci. 2002;30(2):161-166.

Cargill

Schrodi

Chang

et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet. 2007;80(2):273-290.

Nair

Duffin

Helms

et al. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet. 2009;41(2):199-204.

Zhuang

Cai

Zhong

Sun

. Associations between tumor necrosis factor–alpha polymorphisms and risk of psoriasis: a meta-analysis. PLoS One. 2013;8(12):e68827.

Zhao

Xie

Zhang

et al. Update on the association between interleukin-12 p40 gene polymorphism and risk of psoriasis: a meta-analysis. Dermatol Sinica. 2016;34(3):126-130.